@FiercePharma: Top-read special report: The top 10 pharma companies by 2013 revenue. Feature | Follow @FiercePharma
@TracyStaton: FiercePharma's best-read marketing story: Sanofi aims for outcomes with new Chief Patient Officer. Article | Follow @TracyStaton
@EricPFierce: Sources tell Economic Times that Sun will phase out Ranbaxy brand in U.S. Sun doesn't deny it. More | Follow @EricPFierce
@CarlyHFierce: Hamburg to pharma at PhRMA 14, on improving applications: "One message, and I maybe will come to regret it, is really do reach out and engage with us." | Follow @CarlyHFierce
> France has worried pharma with a measure allowing pharmacists to substitute prescribed brand-name biologic drugs with biosimilars. Report
> The FDA has approved Hetlioz, Vanda Pharmaceuticals' ($VNDA) treatment for non-24-hour sleep-wake disorder. Release
> A Florida federal jury has decided that Novartis ($NVS) didn't fail to sufficiently warn a prescribing physician of the risk of jaw injuries supposedly caused by bone drugs Aredia and Zometa. More (sub. req.)
> Two New Jersey men who made hundreds of thousands of dollars trading with insider info on Celgene ($CELG) are headed to federal prison. Story
> An FDA advisory committee recently looked favorably on two competitors to Pfizer's ($PFE) Zyvox, which boasts a $1.4 billion market. More
> Novartis ($NVS) plans to provide two million pediatric antimalarials to Zambia. News
@FierceMedDev: Boston Scientific eyes Israel in global marketing push. News | Follow @FierceMedDev
@VarunSaxena2: ICYMI: Adaptive Biotechnologies raises $120M to bolster its immune Dx. Article | Follow @VarunSaxena2
@EmilyWFierce: U.S. and European docs want to put the kibosh on renal denervation devices. Story | Follow @EmilyWFierce
@MichaelGFierce: ICYMI from FierceDrugDelivery: Nanoballoons 'pop' open to deliver cancer drugs when hit with a red laser. Story | Follow @MichaelGFierce
> Abbott creeps toward the FDA with its dissolvable stent. More
> Tendyne raises $25M in Series C financing for mitral valve device. Article
Biotech News
@FierceBiotech: Biogen's hemophilia hopeful scores a PhIII win as FDA awaits. News | Follow @FierceBiotech
@JohnCFierce: Celladon's heart drug grabs 'breakthrough' status at FDA. Item | Follow @JohnCFierce
@DamianFierce: As $GILD gets pilloried over pricing, $BMY (Article) and $MRK (Story) creep up in hep C. | Follow @DamianFierce
@EmilyMFierce: WHO offers road map for new vaccine introduction. Article | Follow @EmilyMFierce
> Soon after media storm fades, Chimerix CEO Moch is out the door. More
Pharma Manufacturing News
> Neuland opens API plant as part of its partnership with Mitsubishi. More
> Kyowa Hakko Kirin finishes $60M biologics API plant. Story
> Sources: Sun has blueprint for turning Ranbaxy around. Article
> AbbVie partners with Arabio for production in Saudi Arabia. More
> Novartis' government-backed vaccine plant should be operational by 2017. Item
Vaccines News
> Merck KGaA lung cancer vaccine gets a second shot with start of PhIII trial. Story
> Colorado Senate hears vaccine bill testimony. Item
> Report: Emergency flu vaccine manufacturing site will be online by 2017. Article
> Novartis' Bexsero wins FDA 'breakthrough' status. More
And Finally... Eye doctors say their profits are smaller than Medicare makes them look. Report (sub. req.)